Novartis Suspends Production

Late last month, Novartis quietly suspended production at a plant in Lincoln, Nebraska, where various over-the-counter and animal health meds are manufactured. The drugmaker is calling the move a voluntary step that is being taken for “compliance  improvement activities” and to “expedite maintenance and improvements and       continue to strengthen standards.” As a    result, supplies of various popular over-the-counter products will be affected, including Excedrin, Theraflu, Triaminic, Maalox and Lamisil (read here). As for veterinarians, the popular Interceptor and Sentinel treatments for heartworm will also be harder to come by (see this). A Novartis spokeswoman was unable to say how long the shutdown will occur or whether the action was precipitated by regulatory inspections.


This entry was posted in Industry Updates. Bookmark the permalink.

Comments are closed.